Ikarian Capital’s Traws Pharma TRAW Stock Holding History

Ikarian Capital’s Portfolio TRAW Stock Details TRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.24M	Hold	678,142	–	–	0.1%	108
2025 Q4	$766K	Buy	678,142 +649,649	+2,280%	+$1.44M	0.06%	132
2025 Q3	$52.7K	Hold	28,493	–	–	0.01%	165
2025 Q2	$42.2K	Hold	28,493	–	–	0.01%	129
2025 Q1	$65.5K	Sell	28,493 -70,000	-71%	-$364K	0.01%	154
2024 Q4	$875K	Buy	+98,493	New	+$548K	0.12%	112
2022 Q2	–	Sell	-759	Closed	-$35K	–	209
2022 Q1	$35K	Buy	759 +156	+26%	+$7.23K	﹤0.01%	188
2021 Q4	$37K	Hold	603	–	–	0.01%	176
2021 Q3	$57K	Sell	603 -326	-35%	-$42K	﹤0.01%	208
2021 Q2	$161K	Sell	929 -2,125	-70%	-$481K	0.01%	208
2021 Q1	$1.14M	Buy	+3,054	New	+$1.15M	0.04%	233

Other funds holding TRAW

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $273M AUM

DIG

Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PWM

Palumbo Wealth Management Great Neck, New York $478M AUM 50.95% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Ikarian Capital's TRAW Position: Q1 2026 in Review

Ikarian Capital held its Traws Pharma (TRAW) position steady in Q1 2026 at 678,142 shares worth $1.24M. The position accounts for 0.1% of the portfolio, ranked #108.

Ikarian Capital first reported a position in TRAW in Q1 2021 and has held it in 11 quarters since. 28 funds tracked by Wall St. Rank hold TRAW as of Q1 2026.

Ikarian Capital held 678,142 shares of Traws Pharma worth $1.24M as of Q1 2026.
Ikarian Capital left its Traws Pharma share count unchanged in Q1 2026.
Traws Pharma made up 0.1% of Ikarian Capital's portfolio in Q1 2026, its #108 holding.
Ikarian Capital first reported a position in Traws Pharma in Q1 2021 and has held it in 11 quarters since.
28 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2026.

Based on Ikarian Capital's 13F filing for Q1 2026, filed 15 May 2026.